Roivant outlines Investor Day focus as IMVT-1402 targets 85,000 difficult-to-treat RA patients
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Trial Stopped Early for Superiority of LBBP-Tuned Pacemakers
(MedPage Today) -- Left bundle branch pacing (LBBP) drastically reduced clinical events among patients with atrioventricular (AV) block, with results good enough to stop the OptimPacing trial early.
Namibia: Air Ambulance to Bridge Healthcare Gap in Remote Areas
[New Era] Namibia's first State-owned air ambulance service is expected to improve access to specialised medical care for patients in remote areas, where long distances to referral hospitals have…
10 ways to tell cold, flu, COVID and RSV symptoms apart
Cold vs flu vs COVID vs RSV symptoms often overlap; these 10 slides explain how each illness starts, how testing and treatment differ and when to seek care